Improving symptoms and side effects in older patients with schizophrenia with decreasing dopamine D2/3 receptor occupancy following risperidone and olanzapine dose reduction.

The article offers information on a study conducted by A. Graff-Guerrero and colleagues on improving symptoms of patients with schizophrenia. Topics discussed include suggestion to use lower doses of antipsychotics for older patients with schizophrenia, research to identify potential candidates for antipsychotic dose reduction, and exacerbation in patients with low baseline dopamine receptor occupancy.